VS

Vinit Singh Sengar

Director Director DIN 06495893
DIN 06495893 First appointment Jan 2014 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Vinit Singh Sengar

Data last updated:

Vinit Singh Sengar was a Director at Supra Remedies Private Limited (2014–2021) and Director at Multiple Health Care Services Private Limited (from 2014). The companies operate in Healthcare.

DIN 06495893
Primary Designation Director
Industry Healthcare
First Appointment 23 Jan 2014
Oldest Company Age 11 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Supra Remedies Private Limited U85100MP2014PTC032235
Director23 Jan 20142014Strike Off
Director24 Nov 20142014Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Multiple Health Care Services Private Limited
Supra Remedies Private Limited
Premium access

Shareholding and investment profile for Vinit Singh Sengar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vinit Singh Sengar

Vinit Singh Sengar was first appointed on 23 Jan 2014 as Director at Supra Remedies Private Limited.

Vinit Singh Sengar held 2 earlier board appointments: Supra Remedies Private Limited (Director, 23 Jan 2014 to 11 Oct 2021); Multiple Health Care Services Private Limited (Director, from 24 Nov 2014).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available